- Home
- PTHL vs SST Comparison
PTHL vs SST Comparison
Compare PTHL & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTHL
- SST
- Stock Information
- Founded
- PTHL 1998
- SST 2013
- Country
- PTHL China
- SST United States
- Employees
- PTHL N/A
- SST N/A
- Industry
- PTHL
- SST Diversified Commercial Services
- Sector
- PTHL
- SST Consumer Discretionary
- Exchange
- PTHL Nasdaq
- SST Nasdaq
- Market Cap
- PTHL 72.9M
- SST 83.4M
- IPO Year
- PTHL 2024
- SST N/A
- Fundamental
- Price
- PTHL $4.54
- SST $1.08
- Analyst Decision
- PTHL
- SST Hold
- Analyst Count
- PTHL 0
- SST 1
- Target Price
- PTHL N/A
- SST $2.00
- AVG Volume (30 Days)
- PTHL 295.9K
- SST 110.4K
- Earning Date
- PTHL 11-11-2024
- SST 11-07-2024
- Dividend Yield
- PTHL N/A
- SST N/A
- EPS Growth
- PTHL N/A
- SST N/A
- EPS
- PTHL N/A
- SST N/A
- Revenue
- PTHL $572,291.00
- SST $363,437,000.00
- Revenue This Year
- PTHL N/A
- SST N/A
- Revenue Next Year
- PTHL N/A
- SST $15.17
- P/E Ratio
- PTHL N/A
- SST N/A
- Revenue Growth
- PTHL 2.32
- SST N/A
- 52 Week Low
- PTHL $3.32
- SST $1.04
- 52 Week High
- PTHL $6.45
- SST $3.02
- Technical
- Relative Strength Index (RSI)
- PTHL N/A
- SST 41.02
- Support Level
- PTHL N/A
- SST $1.06
- Resistance Level
- PTHL N/A
- SST $1.12
- Average True Range (ATR)
- PTHL 0.00
- SST 0.05
- MACD
- PTHL 0.00
- SST 0.01
- Stochastic Oscillator
- PTHL 0.00
- SST 30.00
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment.